文献速递美容整形乳房整形与再造

患者报告结局指标在整形外科临床试验中的应用:一项系统综述

Utilization of patient-reported outcome measures in plastic surgery clinical trials: A systematic review.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-02-02

该系统综述评估2012至2022年美国整形与重建外科临床试验中患者报告结局(PRO)的使用情况。共纳入154项试验,其中80项使用了PRO,涉及13190名参与者,95%为女性。疼痛(35%)和患者满意度(24%)是最常见的主要结局,验证性量表为主要结局的占61%,使用验证性PRO的趋势不显著。

要点

  • 154项整形外科临床试验中,80项(约半数)使用了患者报告结局(PRO)。
  • 验证性PRO为主要结局的占61%,最常用工具为视觉模拟量表(19%)和BREAST-Q(15%)。
  • 十年间验证性PRO的使用趋势无显著变化。

核心结论

  • PRO在整形外科临床试验中的使用具有相关性,但仅略超过半数试验报告了PRO,且验证性量表的使用不一致。

研究设计与样本

  • 系统综述,由医学图书馆员制定检索策略,检索2012至2022年间的美国整形与重建外科临床试验,最终纳入154项试验。

主要发现

  • 154项试验中80项使用了PRO,涉及13190名参与者,其中95%(12229名)为女性。
  • 使用PRO的试验中,37项(48%)属于重建领域,25项(32%)属于美容领域。
  • 疼痛(35%)和患者满意度(24%)是最常见的PRO主要结局。
  • 验证性PRO为主要结局的占61%,最常用工具为视觉模拟量表(19%)和BREAST-Q(15%)。
  • 资金来源主要为私人(34%)或未报告(49%),十年间验证性PRO使用无显著趋势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient-reported outcomes (PROs) have evolved to validated questionnaires assessing health-related quality of life. This systematic review evaluates the utilization of PROs in United States plastic and reconstructive surgery (PRS) clinical trials (CTs). METHODS: A medical librarian conducted a search strategy for PRS CTs from 2012 to 2022. CTs were identified and assessed for PRO utilization. Summary statistics were performed, and Fisher's exact test was used for subgroup analysis. RESULTS: Of the 3609 studies initially identified, 154 were PRS CTs. Approximately half (80 studies) employed PROs, encompassing 13,190 participants, 95% (12,229) of whom were female. Among the CTs, 37 (48%) were in the field of reconstruction, while 25 (32%) were cosmetic. Pain (35%) and patient satisfaction (24%) were the most common primary outcomes. Validated PROs were the main outcome in 61% of these trials, with the visual analog scale (19%) and BREAST-Q (15%) as the top instruments. Funding was primarily private (34%) or not reported (49%). No significant trend in validated PRO usage was observed over the examined decade. CONCLUSIONS: The use of PROs is relevant for healthcare delivery and improvement as they provide insight into the efficacy of treatments from a patient-centered viewpoint. PROs are reported in just over half of PRS CTs, and within those CTs, the use of validated questionnaires is inconsistent. Therefore, emerging CTs should strive to incorporate PRO measures and utilize the existing validated tools to assess novel interventions and ensure that the data reported is objective.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Foppiani J, Alvarez AH, Stearns SA, et al. Utilization of patient-reported outcome measures in plastic surgery clinical trials: A systematic review. J Plast Reconstr Aesthet Surg. 2024. PMID: 38387418. doi:10.1016/j.bjps.2024.01.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。